Galmed Pharmaceuticals Statistics
Total Valuation
GLMD has a market cap or net worth of $3.65 million. The enterprise value is -$15.40 million.
| Market Cap | 3.65M |
| Enterprise Value | -15.40M |
Important Dates
The next estimated earnings date is Wednesday, April 1, 2026, before market open.
| Earnings Date | Apr 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GLMD has 6.58 million shares outstanding. The number of shares has increased by 474.24% in one year.
| Current Share Class | 6.58M |
| Shares Outstanding | 6.58M |
| Shares Change (YoY) | +474.24% |
| Shares Change (QoQ) | +38.30% |
| Owned by Insiders (%) | 0.99% |
| Owned by Institutions (%) | 6.03% |
| Float | 6.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.16 |
| P/TBV Ratio | 0.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.98
| Current Ratio | 7.98 |
| Quick Ratio | 7.93 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.66 |
Financial Efficiency
Return on equity (ROE) is -46.34% and return on invested capital (ROIC) is -23.68%.
| Return on Equity (ROE) | -46.34% |
| Return on Assets (ROA) | -20.90% |
| Return on Invested Capital (ROIC) | -23.68% |
| Return on Capital Employed (ROCE) | -37.21% |
| Weighted Average Cost of Capital (WACC) | 6.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.45M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.49% in the last 52 weeks. The beta is 0.38, so GLMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -79.49% |
| 50-Day Moving Average | 0.78 |
| 200-Day Moving Average | 1.30 |
| Relative Strength Index (RSI) | 32.33 |
| Average Volume (20 Days) | 84,170 |
Short Selling Information
| Short Interest | 55,704 |
| Short Previous Month | 61,515 |
| Short % of Shares Out | 1.03% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.11M |
| Pretax Income | -8.70M |
| Net Income | -8.70M |
| EBITDA | -7.05M |
| EBIT | -7.11M |
| Earnings Per Share (EPS) | -$2.71 |
Balance Sheet
The company has $19.05 million in cash and n/a in debt, with a net cash position of $19.05 million or $2.89 per share.
| Cash & Cash Equivalents | 19.05M |
| Total Debt | n/a |
| Net Cash | 19.05M |
| Net Cash Per Share | $2.89 |
| Equity (Book Value) | 19.11M |
| Book Value Per Share | 3.49 |
| Working Capital | 17.25M |
Cash Flow
| Operating Cash Flow | -6.28M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.28M |
| FCF Per Share | -$0.95 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GLMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -474.24% |
| Shareholder Yield | -474.24% |
| Earnings Yield | -238.40% |
| FCF Yield | -172.03% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 30, 2024. It was a reverse split with a ratio of 1:12.
| Last Split Date | Aug 30, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |